In this Talk Evidence, Helen Macdonald, Joe Ross and Duncan Jarvies discuss what's going on in the world of EBM.
Firstly, a while ago on the podcast, we concluded that excess mortality would be the best way to measure the impact of the pandemic - and now a new paper looks at different country's excess mortalitites over the past year. We're joined by author ... Show More
May 8
Revisiting the Cass Review on gender identity services, and non-invasive brain stimulation for children with autism
The BMA has released their long awaited review of the Cass report. The original report looked at the provision of NHS gender identity services for children and young people, and involved a review of the science underpinning those services. It also set out a plan to improve care f ... Show More
39m 30s
Apr 24
MS drug controversy, adoption outcomes in Sweden, and the multi-factorial reality of Alzheimer’s
A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple sclerosis, following a patient petition that highlighted internal disagreements among agency reviewers regarding its efficacy. We look to Sweden, w ... Show More
38m 30s
Jun 2022
Talk Evidence - political persuasion and mortality, too much medicine
In this week's episode, Helen Macdonald is joined by Joseph Ross, US research editor for The BMJ, and Juan Franco, editor of BMJ EBM.
They begin by discussing a review of obesity interventions in primary care, and Joe wonders if GPs are really the best people to tackle the issue. ... Show More
41m 6s
Dec 2023
Dec 15 2023 This Week in Cardiology
<p>FDA approves PFA, breakthrough in PAH, residual leaks after percutaneous LAAO, OAC in low to intermediate risk people are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>. To read a parti ... Show More
29m 5s
Oct 2018
Prognosis, a New Show From Bloomberg
Where does a medical cure come from? 100 years ago, it wasn't uncommon for scientists to test medicines by taking a dose themselves. As medical technologies get cheaper and more accessible, patients and DIY tinkerers are trying something similar—and mainstream medicine is racing ... Show More
1m 32s
Aug 2023
Aug 11, 2023 This Week in Cardiology Podcast
<p>Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p>This podcast is intended for healthcare professionals only. To read a p ... Show More
29m 25s
Nov 2023
Nov 10 2023 This Week in Cardiology
<p>Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or t ... Show More
24 m
Dec 2015
Michael Greger, M.D. On How Not To Die
“I continue to be amazed by our bodies' ability for self-repair. Our bodies want to be healthy, if we would just let them. That's what these new research articles are showing: even after years of beating yourself up with a horrible diet, your body can reverse the damage, open bac ... Show More
1h 44m
May 2024
May 10 2024 This Week in Cardiology
<p>Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To rea ... Show More
31m 56s